NeoCore Technology Co., Ltd. (TPEX:4131)
32.50
+0.15 (0.46%)
Aug 26, 2026, 1:08 PM CST
NeoCore Technology Revenue
NeoCore Technology had revenue of 95.70M TWD in the quarter ending June 30, 2026, with 78.21% growth. This brings the company's revenue in the last twelve months to 277.54M, up 83.35% year-over-year. In the year 2025, NeoCore Technology had annual revenue of 244.66M with 297.52% growth.
Revenue (ttm)
277.54M
Revenue Growth
+83.35%
P/S Ratio
4.65
Revenue / Employee
6.31M
Employees
44
Market Cap
1.29B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 244.66M | 183.11M | 297.52% |
| Dec 31, 2024 | 61.55M | -3.18M | -4.92% |
| Dec 31, 2023 | 64.73M | -24.24M | -27.24% |
| Dec 31, 2022 | 88.97M | 42.00K | 0.05% |
| Dec 31, 2021 | 88.93M | -4.42M | -4.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GenMont Biotech Incorporation | 382.11M |
| Abnova (Taiwan) | 345.45M |
| Lukas Biomedical | 170.01M |
| Enimmune | 53.45M |
| TaiRx | 29.44M |